OpenBilldrug price receipt

NADAC week of 2026-10-14

CLINDA-TRETINOIN 1.2%-0.025%

FDA nonproprietary name: clindamycin phosphate and tretinoin

For 1 g

Pharmacies pay

$3.51 – $4.31 filed

1 × $3.50632 to $4.31193 per GM (the 6 NDCs differ)

CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17

Medicare Part D paid

$7.24 filed

1 × $7.24009 per GM, Part D average

Medicare's price is not your price.

Medicare Part D · DSD_PTD_RY26_P04_V10_DY24_BGM.csv · eff. 2024-01-01 to 2024-12-31 · as of 2026-06-25 · retrieved 2026-10-18

The spread

1.7× – 2.1× estimated

Medicare paid between 1.7× and 2.1× what pharmacies pay, depending on the NDC.

Part D averages every strength and form sold under “Clindamycin Phos-Tretinoin” / “Clindamycin/Tretinoin” into one figure, so it is not specific to this NDC.

OpenBill calculation · DSD_PTD_RY26_P04_V10_DY24_BGM.csv + nadac-national-average-drug-acquisition-cost-20261014.csv · NADAC eff. 2026-09-23 (file of 2026-10-14, retrieved 2026-10-17) · Part D 2024-01-01 to 2024-12-31 (file of 2026-06-25, retrieved 2026-10-18)

Cost-plus estimate

$9.04 – $9.96 estimated

NADAC for the pack + 15% + $5.00 fee per fill

This is a model, not a price any pharmacy quoted. Shipping is not included. For a pack this cheap, the $5.00 fee is most of the estimate. How it is worked out

OpenBill calculation · nadac-national-average-drug-acquisition-cost-20261014.csv · NADAC eff. 2026-09-23 (file of 2026-10-14, retrieved 2026-10-17)

Open the interactive card Change the quantity, type what you were charged, and see every record in full.

What it is

CLINDA-TRETINOIN 1.2%-0.025% is how the CMS NADAC file names this product. The FDA NDC Directory lists it as “clindamycin phosphate and tretinoin” and “clindamycin phosphate and tretinoin gel 1.2%/0.025%”, as its NDCs’ listings variously write the nonproprietary name.

FDA gives its dosage form as gel and its route as topical.

Its labelers, the companies named on the label, are Actavis Pharma, Inc., Encube Ethicals, Inc. and Solaris Pharma Corporation.

FDA lists it under 2 Established Pharmacologic Classes: Lincosamide Antibacterial and Retinoid.

The NADAC file of 2026-10-14 prices it under 6 NDCs (National Drug Codes).

NADAC classes it as a generic drug (rate-setting class G), and does not mark it as sold over the counter.

What pharmacies pay

Pharmacies pay $3.51 – $4.31 for 1 g, depending on the NDC ($3.50632 to $4.31193 per GM), by the CMS NADAC file of 2026-10-14; that price took effect on 2026-09-23. That is what pharmacies pay their suppliers, not what they charge you.

NADAC’s explanation codes for it: 1, calculated from the most recently completed pharmacy survey; 5, calculated based on package size.

What NADAC measures · NADAC explanation codes

All 6 NDCs

Compared with its class

The middle of its 6 NDCs’ NADAC prices is $3.50632 per GM filed.

Of the 12 other products in FDA’s Lincosamide Antibacterial class priced per GM, 2 have a higher middle NADAC price and 10 a lower one. The one in the middle is CLEOCIN 2% VAGINAL CREAM, at $1.79228 per GM filed (eff. 2026-09-23).

Of the 23 other products in FDA’s Retinoid class priced per GM, 10 have a higher middle NADAC price and 13 a lower one. The one in the middle is TRETINOIN 0.025% GEL, at $2.50019 per GM filed (eff. 2026-09-23).

Prices are compared per unit, whatever the strength or dose, and a class is not a list of substitutes.

CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17

How the class comparison works

What Medicare paid

Medicare Part D paid $7.24 for 1 g, at an average of $7.24009 per GM in 2024 (2024-01-01 to 2024-12-31) for “Clindamycin Phos-Tretinoin” and “Clindamycin/Tretinoin”, every strength and form sold under that name together (Medicare Part D Spending by Drug, file of 2026-06-25).

That average covers 428 Part D claims (fills, including refills) for 2024-01-01 to 2024-12-31, across every maker, strength and form under the name.

4 of the product’s 6 NDCs have this Medicare figure; the other 2 do not, and the interactive card says why for each.

Medicare's price is not your price.

What Part D spending measures · Which Medicare figure OpenBill compares · How the spread is worked out

What to ask at the counter

None of these figures is your price: what you pay depends on your pharmacy, your insurance, coupons and discounts.

Questions

Why is the comparison with Medicare for CLINDA-TRETINOIN 1.2%-0.025% labelled estimated?
Beyond what the card shows, the records give these reasons: The Part D figure covers 2024-01-01 to 2024-12-31; the NADAC price is from the file of 2026-10-14. Part D spending basis, as the Part D record states it: Part D 2024 average spend per dosage unit for Clindamycin Phos-Tretinoin / Clindamycin/Tretinoin: all makers, strengths, forms and routes combined, claim-weighted; gross cost incl. dispensing fees and patient pay, before rebates. Unit taken as NADAC's GM. Joined on generic name.
Why does this page start at 1 g?
The FDA package descriptions of this product’s NDCs give different amounts (30 g, 60 g). So the card starts at 1 GM; change it to match your prescription.

Its pharmacologic classes

Related in the same class

More